NIAID Support for the Development of Phage Therapy
Time: 1:00 pm
day: Day One
- DMID/NIAID pre-clinical services are used to explore the efficacy of bacteriophages in vivo and in vitro
- Biopharmaceutical Products Therapeutic Development Services Task Orders are used to Craft Product Development Plans
- DMID/NIAID genomic services are used to analyze bacteriophage genomes
- Funding of solicited and un-solicited grants to explore and develop the therapeutic bacteriophages and their gene products.